From the Analyst's Couch | Published:

Systemic lupus erythematosus and lupus nephritis

Nature Reviews Drug Discovery volume 13, pages 173174 (2014) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    & PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis — Global Drug Forecast and Market Analysis to 2022 (GlobalData, 2013).

  2. 2.

    & Unmet medical needs in systemic lupus erythematosus. Arthritis Res. Ther. 14, S4 (2012).

Download references

Author information


  1. GlobalData, 40–42 Hatton Garden, London EC1N 8EB, UK.

    • Toli Koutsokeras
  2. GlobalData, 40–42 Hatton Garden, London EC1N 8EB, UK.

    • Tina Healy


  1. Search for Toli Koutsokeras in:

  2. Search for Tina Healy in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Toli Koutsokeras or Tina Healy.

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing